SCHEMBL3363182

SCHEMBL3363182

O=CCc1cccc(Cl)n1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.42
TSHR P16473 1/20 0.42
ALDH1A1 P00352 4/20 0.35
GAA P10253 2/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
AGTR1 P30556 1/20 0.35
NFE2L2 Q16236 5/20 0.33
MBOAT4 Q96T53 1/20 0.33
PGK1 P00558 1/20 0.32
PGK2 P07205 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
ADRB1 P08588 1/20 0.32
ADRB3 P13945 1/20 0.32
GRM2 Q14416 1/20 0.31
GRM3 Q14832 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22482055 0.84 PGK1 (0.43) PGK1PGK2
SCHEMBL13680820 0.80 CYP3A4 (0.39) CYP3A4TSHRALDH1A1GAAMAPT
Formic Acid SCHEMBL28289297 0.80 CYP3A4 (0.36) CYP3A4TSHRALDH1A1GAAMAPT
SCHEMBL11495887 0.76 CYP3A4 (0.35) CYP3A4TSHRALDH1A1GAAMAPT
SCHEMBL7052424 0.76
SCHEMBL247492 0.75 SMN1; SMN2 (0.44) CYP3A4TSHRALDH1A1HPGDMBOAT4
SCHEMBL20400755 0.75 CCR1 (0.40) PGK1PGK2
SCHEMBL20730061 0.75 PGK1 (0.41) PGK1PGK2
SCHEMBL4287573 0.75 MBOAT4 (0.33) MBOAT4PGK1PGK2
SCHEMBL6745 0.75 PARP1 (0.38) ALDH1A1HPGDMBOAT4PGK1PGK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4514802-A1 IMIDAZOLE DERIVATIVES AS ALK5 INHIBITORS Chiesi Farmaceutici S.p.A. (IT) 2025-03-05 EP disclosed
WO-2023208986-A1 IMIDAZOLE DERIVATIVES AS ALK5 INHIBITORS CHIESI FARMACEUTICI S.P.A. (IT) 2023-11-02 WO disclosed
WO-2018055578-A1 PREVENTIVE AND THERAPEUTIC APPROACH FOR ABERRANT CELL DIFFERENTIATION AND ISR-ASSOCIATED DISEASES THE UNIVERSITY OF HONG KONG (CN) 2018-03-29 WO disclosed
WO-2010046780-A2 ANTI VIRAL COMPOUNDS INSTITUT PASTEUR KOREA (KR) 2010-04-29 WO disclosed